Showing 281 - 300 results of 326 for search '"neurological disease"', query time: 0.09s Refine Results
  1. 281

    Bindarit attenuates neuroinflammation after subarachnoid hemorrhage by regulating the CCL2/CCR2/NF-κB pathway by Yanting Yao, Qiaowei Wu, Kaikun Yuan, Pei Wu, Chao Xu, Zhiyong Ji, Weishi Xu, Hongli Yu, Anyu Xu, Yanchen Liu, Huaizhang Shi

    Published 2025-01-01
    “…The CCL2/CCR2 signaling axis, a cytoplasmic pathway responsible for recruiting immune cells, plays a significant role in regulating neuroinflammation in neurological diseases. Bindarit, an inhibitor of chemokine CC motif ligand 2(CCL2), has been shown to demonstrate neuroprotective effects in various central nervous system diseases. …”
    Get full text
    Article
  2. 282
  3. 283

    Research Progress of Transcranial Direct Current Stimulation Therapy for Cognitive Impairment after Stroke by LIU Yuanchen, ZHANG Lixin

    Published 2024-06-01
    “…Compared with cognitive impairment caused by other neurological diseases, preventability and treatability are important characteristics of PSCI, making early intervention particularly important. …”
    Get full text
    Article
  4. 284
  5. 285

    Applications of Ultrasonic Brain Imaging and Transcranial Ultrasound Therapy in Brain Injury Rehabilitation by WU Yi

    Published 2023-04-01
    “…High intensity focused ultrasound (HIFU) and low intensity focused ultrasound (LIFU) use the thermal and mechanical effects respectively to perform tissue ablation, blood-brain barrier opening, drug targeted delivery, ultrasound-assisted catheter-directed thrombolysis and neuromodulation, and can be applied to the treatment of brain tumors, brain trauma, stroke, Parkinson's disease, Alzheimer's disease, epilepsy, depression and other neurological diseases and mental diseases. At present, ultrasound brain imaging and therapeutic transcranial ultrasound are still in development. …”
    Get full text
    Article
  6. 286
  7. 287
  8. 288
  9. 289

    Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis by Işıl Peker, Hacer Eroğlu İçli, Belgin Mutluay, Burcu Yüksel, Zeynep Özdemir, Mesrure Köseoğlu, Aysu Şen, Dilek Ataklı, Aysun Soysal, Musa Öztürk

    Published 2024-12-01
    “…<b>Methods:</b> Forty-two patients with MS were enrolled, along with 22 controls, 12 of the controls were idiopathic intracranial hypertension (IIH) patients, and 10 of the controls were other neurologic diseases (OND). Chemokine levels were measured using enzyme-linked immunosorbent assay (ELISA) in serum and cerebrospinal fluid (CSF) samples. …”
    Get full text
    Article
  10. 290

    The role of olfactory transport in the penetration of manganese oxide nanoparticles from blood into the brain by A. V. Romashchenko, M. B. Sharapova, К. N. Morozova, E. V. Kiseleva, K. E. Kuper, D. V. Petrovskii

    Published 2019-07-01
    “…The accumulation of NPs in CNS can provoke many neurological diseases; therefore, the understanding of its mechanisms is of both academic and practical interest. …”
    Get full text
    Article
  11. 291

    Relationship Between Bi-Caudate Ratio and White Matter Atrophy in Brain MRI of Multiple Sclerosis by Hussein Soleimantabar, Shno Hosseini

    Published 2025-01-01
    “…Background: Multiple sclerosis (MS) is one of the most common and debilitating neurological diseases. Brain magnetic resonance imaging (MRI) is critical to determine the prognosis of MS. …”
    Get full text
    Article
  12. 292

    Astrocyte-Derived Interleukin 11 Modulates Astrocyte–Microglia Crosstalk via Nuclear Factor-κB Signaling Pathway in Sepsis-Associated Encephalopathy by Dandan Zhu, Peng Wang, Xiyue Chen, Kaituo Wang, Yunsong Wu, Min Zhang, Jianhua Qin

    Published 2025-01-01
    “…The astrocyte–microglia crosstalk in the central nervous system (CNS) plays important roles in various neurological diseases. However, how astrocytes interact with microglia to regulate neuronal injury in SAE is poorly defined. …”
    Get full text
    Article
  13. 293

    Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis by P. P. Sainaghi, L. Collimedaglia, F. Alciato, R. Molinari, D. Sola, E. Ranza, P. Naldi, F. Monaco, M. Leone, M. Pirisi, G. C. Avanzi

    Published 2013-01-01
    “…Forty patients affected by noninflammatory/nonautoimmune neurological diseases served as controls. Relapse was defined according to Schumacher criteria. …”
    Get full text
    Article
  14. 294

    Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO by Vidya Narayanaswami PhD, Kenneth Dahl PhD, Vadim Bernard-Gauthier PhD, Lee Josephson PhD, Paul Cumming PhD, Neil Vasdev PhD

    Published 2018-09-01
    “…Although initiation of an inflammatory response may be beneficial in response to injury of the nervous system, chronic or maladaptive neuroinflammation can have harmful outcomes in many neurological diseases. An acute neuroinflammatory response is protective when activated neuroglia facilitate tissue repair by releasing anti-inflammatory cytokines and neurotrophic factors. …”
    Get full text
    Article
  15. 295

    The research progress on effective connectivity in adolescent depression based on resting-state fMRI by Xuan Deng, Jiajing Cui, Jinyuan Zhao, Jinji Bai, Junfeng Li, Kefeng Li

    Published 2025-02-01
    “…However, effective connection can reflect the upper and lower relationship of brain region interaction, and provide help for us to explore the mechanism of neurological diseases. Existing studies focus on the analysis of a single brain network, but rarely explore the interaction between multiple key networks.DiscussionTo do so, we can address these issues by integrating multiple technologies. …”
    Get full text
    Article
  16. 296
  17. 297
  18. 298
  19. 299

    The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy by Lin Wang, Qingxia Kong, Xinyi Leng, Howan Leung, Yang Li

    Published 2025-02-01
    “…Abstract Epilepsy is one of the common chronic neurological diseases, affecting more than 70 million people worldwide. …”
    Get full text
    Article
  20. 300

    Diurnal variation in brain injury after cardiac arrest and cardiopulmonary resuscitation by Fei Peng, Fei Wang, Bowen Gao, Ping Sun

    Published 2025-02-01
    “…BackgroundAlthough the circadian rhythm is known to influence several neurological diseases and response to treatments, its potential impact on brain injury following cardiac arrest and cardiopulmonary resuscitation (CA/CPR) remains unclear.MethodsWe performed a retrospective observational study on out-of-hospital cardiac arrest (OHCA) cases that presented to the emergency department of our hospital between September 2022 and August 2024. …”
    Get full text
    Article